» Articles » PMID: 30455812

[Difficulties in Managing Graves' Disease in Children: About a Case]

Overview
Journal Pan Afr Med J
Date 2018 Nov 21
PMID 30455812
Authors
Affiliations
Soon will be listed here.
Abstract

Adequate management of Graves' disease in children is an area of controversy in pediatric endocrinology, while optimal duration of medical treatment inducing remission in disease as well as indications for therapeutic alternatives still needs to be determined. We report the case of a 11-year old female child with no particular past medical history., presenting with progressive weight loss associated with diarrhea. Her parents brought the child to hospital because neighbours noticed anterior cervical swelling on her. Clinical and paraclinical data helped to retain the diagnosis of Graves' disease. The patient underwent medical treatment with carbimazole. Patient's evolution was marked by the occurrence of thrombocytopenia, suggesting prudent administration of medical treatment. Iratherapy was indicated due to the absence of remission after 4 years of treatment. Although rare, Graves' disease is the first cause of hyperthyroidism in children. Positive diagnosis is easy but its management may pose enormous problems. Medical treatment is based on synthetic antithyroid drugs, but they are not always innocuous, as in the case of our patient. Then subtotal thyroidectomy or radioactive iodine treatment are two therapeutic alternatives. Graves' disease is a rare and severe disease in children posing considerable management difficulties.

References
1.
Weetman A . Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?. Nat Clin Pract Endocrinol Metab. 2006; 2(1):2-3. DOI: 10.1038/ncpendmet0068. View

2.
Lippe B, Landaw E, Kaplan S . Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab. 1987; 64(6):1241-5. DOI: 10.1210/jcem-64-6-1241. View

3.
Rivkees S, Szarfman A . Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab. 2010; 95(7):3260-7. DOI: 10.1210/jc.2009-2546. View

4.
Glaser N, Styne D . Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study. Pediatrics. 2008; 121(3):e481-8. DOI: 10.1542/peds.2007-1535. View

5.
Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M . Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab. 2000; 85(10):3678-82. DOI: 10.1210/jcem.85.10.6922. View